Approval · Notice of Compliance 11065 · 2010
FLUOXETINE: Notice of Compliance 11065
Issued February 18, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11065
- Date
- February 18, 2010
- Company
- Meliapharm IncMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antidepressant / Antiobsessional / Antibulimic
- Canadian reference product
- PROZAC (Eli Lilly Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUOXETINE | 02344149 | Cancelled Post Market |
| FLUOXETINE | 02344157 | Cancelled Post Market |
Medicinal ingredients
- FLUOXETINE HYDROCHLORIDE 10 MG per CAP
- FLUOXETINE HYDROCHLORIDE 20 MG per CAP